Jim Cramer says he supports healthcare stocks for their long-term value
1. Cramer advocates for long-term investments in pharmaceutical stocks. 2. He believes future prospects for drug makers are undervalued. 3. Eli Lilly's stock dropped 6% due to revised revenue guidance. 4. Cramer sees potential in GLP-1 drugs and Eli Lilly's resources. 5. Merck and Regeneron also have strong growth potential and portfolios.